Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Animal models indicate that the antimicrobial peptide hepcidin (HAMP; OMIM 606464) is probably a key regulator of iron absorption in mammals. Here we report the identification of two mutations (93delG and 166C-->T) in HAMP on 19q13 in two families with a new type of juvenile hemochromatosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Deficits in hepcidin-mediated regulation of FPN, often due to hereditary hemochromatoses, lead to iron overload and widespread tissue damage affecting the liver, heart, pancreas, and joints 11-13 .”
From Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms (2020) · cites this paper as [11]
In the citing paper
“There is a single human hepcidin gene whose essential role in iron homeostasis was confirmed by identifying homozygous frameshift or nonsense mutations in affected individuals with severe juvenile hemochromatosis”
From IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin (2004) · cites this paper as [9]
In the citing paper
“HAMP‐deficient mice and humans present with a severe iron loading phenotype, and injection of synthetic HAMP decreases serum iron concentrations. 39 , 40 , 41”
From The battle for iron in enteric infections (2020) · cites this paper as [40]
In the citing paper
“First, mutations in the hepcidin gene itself (called HAMP) cause hemochromatosis by preventing the production of functional hepcidin protein.161”
From Forging a field: the golden age of iron biology. (2008) · cites this paper as [161]
In the citing paper
“In iron-replete cells, IRP1, which has ∼30% homology to mitochondrial aconitase based on amino acid alignments, loses its affinity for the IRE, and converts to a cytosolic aconitase (127, 263).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [263]
Citations
Cites
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-399 · Cited by 3,664
Hepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168
Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697
LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
Krause, A., Neitz, S., Mägert, H.-J., Schulz, A., Forssmann, W.-G., Schulz-Knappe, P., & Adermann, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01920-7 · Cited by 1,324
Nicolas, G., Bennoun, M., Devaux, I., Beaumont, C., Grandchamp, B., Kahn, A., & Vaulont, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151179498 · Cited by 1,233
Severe iron deficiency anemia in transgenic mice expressing liver hepcidin
Nicolas, G., Bennoun, M., Porteu, A., Mativet, S., Beaumont, C., Grandchamp, B., Sirito, M., Sawadogo, M., Kahn, A., & Vaulont, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072632499 · Cited by 880
The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22
Camaschella, C., Roetto, A., Calì, A., De Gobbi, M., Garozzo, G., Carella, M., Majorano, N., Totaro, A., & Gasparini, P. (2000) · Nature Genetics · doi:10.1038/75534 · Cited by 803
Self-citationWeinstein, D. A., Roy, C. N., Fleming, M. D., Loda, M. F., Wolfsdorf, J. I., & Andrews, N. C. (2002) · Blood · doi:10.1182/blood-2002-04-1260 · Cited by 632
Autosomal-dominant hemochrom-atosis is associated with a mutation in the ferroportin (SLC11A3) gene
Montosi, G., Donovan, A., Totaro, A., Garuti, C., Pignatti, E., Cassanelli, S., Trenor, C. C., Gasparini, P., Andrews, N. C., & Pietrangelo, A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13468 · Cited by 561
Autosomal-dominant hemochrom-atosis is associated with a mutation in the ferroportin (SLC11A3) gene
Montosi, G., Donovan, A., Totaro, A., Garuti, C., Pignatti, E., Cassanelli, S., Trenor, C. C., Gasparini, P., Andrews, N. C., & Pietrangelo, A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113468 · Cited by 557
Cited by
Items 501–600 of 869
Jánosi, A., Andrikovics, H., Vas, K., Bors, A., Hubay, M., Sápi, Z., & Tordai, A. (2004) · Blood · doi:10.1182/blood-2004-09-3508 · Cited by 22
Molecular Mechanisms of Intestinal Iron Transport
Collins, J. F., & Anderson, G. J. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382026-6.00071-3 · Cited by 24
Molecular regulation of hepatic expression of iron regulatory hormone hepcidin
Oates, P. S., & Ahmed, U. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04950.x · Cited by 25
A novel ferroportin mutation in a Canadian family with autosomal dominant hemochromatosis
Morris, T. J., Litvinova, M. M., Ralston, D., Mattman, A., Holmes, D. T., & Lockitch, G. (2005) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2005.07.007 · Cited by 23
Genetics of liver disease in adults
Konkwo, C., Chowdhury, S., & Vilarinho, S. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000408 · Cited by 23
Iron Pathophysiology in Stroke
Almutairi, M. M., Xu, G., & Shi, H. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9589-5_6 · Cited by 22
Tantiworawit, A., Khemakapasiddhi, S., Rattanathammethee, T., Hantrakool, S., Chai‐Adisaksopha, C., Rattarittamrong, E., Norasetthada, L., Charoenkwan, P., Srichairatanakool, S., & Fanhchaksai, K. (2021) · Bioscience Reports · doi:10.1042/bsr20203352 · Cited by 22
“stores in macrophages leading to iron overload [13].”
BackgroundNagayoshi, Y., Nakayama, M., Suzuki, S., Hokamaki, J., Shimomura, H., Tsujita, K., Fukuda, M., Yamashita, T., Nakamura, Y., Sugiyama, S., et al. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.07.012 · Cited by 21
“We amplified all 3 exons of the HAMP gene.”
BackgroundMethodInfluentialStoichiometries of transferrin receptors 1 and 2 in human liver
Chloupková, M., Zhang, A.-S., & Enns, C. A. (2009) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2009.09.004 · Cited by 23
“On the basis of the gene involved, HH is classified as type 1 (hereditary hemochromatosis, HFE) [4], type 2A (hemojuvelin, HFE2) [5], type 2B (hepcidin, HAMP) [6], type 3 (transferrin receptor 2, TFR2) [7], and type 4 (ferroportin, FPN) [8].”
BackgroundHematologic Aspects of Kidney Disease
Brugnara, C., & Eckardt, K. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10056-9 · Cited by 26
Wallace, D. F., Dixon, J. L., Ramm, G. A., Anderson, G. J., Powell, L. W., & Subramaniam, V. N. (2005) · PubMed · Cited by 21
Enns, C. A., Weiskopf, T., Zhang, R. H., Wu, J. J., Jue, S. F., Kawaguchi, M., Kataoka, H., & Zhang, A. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105238 · Cited by 22
“Lack of hepcidin causes juvenile he-mochromatosis, a particularly severe iron overload disorder (7, 8).”
Sistemática diagnóstica en la hiperferritinemia
Altés, A., Pérez-Lucena, M. J., & Bruguera, M. (2013) · Medicina Clínica · doi:10.1016/j.medcli.2013.06.010 · Cited by 21
Données récentes sur le métabolisme du fer : un état de transition
Cadet, E., Gadenne, M., Capron, D., & Rochette, J. (2004) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2004.09.024 · Cited by 28
Molecular mechanism of hepcidin deficiency in a patient with juvenile hemochromatosis
Rideau, A., Mangeat, B., Matthes, T., Trono, D., & Beris, P. (2007) · Haematologica · doi:10.3324/haematol.10545 · Cited by 20
“Juvenile hemochromatosis is the result of mutations affecting hepcidin or hemojuvenil genes.(1,2) Recently we found, in two members of a Portuguese family, that juvenile hemochromatosis was associated with a G→A point mutation at position +14 of the 5’ untranslated region (UTR) of the HAMP gene in the homozygous state.”
BackgroundPonka, P., Tenenbein, M., & Eaton, J. W. (2014) · Elsevier eBooks · doi:10.1016/b978-0-444-59453-2.00041-x · Cited by 20
A computational model to understand mouse iron physiology and disease
Parmar, J. H., & Mendes, P. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006680 · Cited by 22
Iron metabolism gene expression in human skeletal muscle
Polonifi, A., Politou, M., Kalotychou, V., Xiromeritis, K., Tsironi, M., Berdoukas, V., Vaiopoulos, G., & Aessopos, A. (2010) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2010.07.002 · Cited by 22
Self-citationThe small molecule ferristatin II induces hepatic hepcidin expression in vivo and in vitro
Alkhateeb, A. A., Buckett, P. D., Gardeck, A. M., Kim, J., Byrne, S. L., Fraenkel, P. G., & Wessling‐Resnick, M. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00324.2014 · Cited by 19
“Inappropriately low hepcidin results in chronic iron accumulation and eventually the development of hemochromatosis and other pathologies (16, 23, 27, 32).”
BackgroundEvolution of the hepcidin gene in primates
Segat, L., Pontillo, A., Milanese, M., Tossi, A., & Crovella, S. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-120 · Cited by 19
Chen, J., & Enns, C. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.632778 · Cited by 19
“Hereditary hemochromatosis is an autosomal recessive iron overload disease caused by mutations in genes encoding the first identified hereditary hemochromatosis protein, HFE (1), hemojuvelin (2), hepcidin (3), transferrin receptor 2 (TfR2)(2) (4), and ferroportin (5, 6).”
BackgroundMolecular diagnosis of hemochromatosis
Piperno, A. (2013) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2013.763794 · Cited by 20
Ponka, P., Tenenbein, M., & Eaton, J. W. (2007) · Elsevier eBooks · doi:10.1016/b978-012369413-3/50085-9 · Cited by 19
Pietrangelo, A. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.09.003 · Cited by 21
Importance of Iron Absorption in Human Health: An Overview
Dixit, S. P., Logesh, R., Palaniswamy, D. S., & Mohankumar, S. K. (2020) · Current Nutrition & Food Science · doi:10.2174/1573401316999200801021752 · Cited by 21
Recent Developments in Liver Pathology
Yan, B. C., & Hart, J. A. L. (2009) · Archives of Pathology & Laboratory Medicine · doi:10.5858/133.7.1078 · Cited by 22
Does the SLC40A1 gene modify HFE-related haemochromatosis phenotypes?
Altés, A., Bach, V., Ruiz, A., Esteve, A., Remacha, A. F., Sardà, M. P., Félez, J., & Baiget, M. (2008) · Annals of Hematology · doi:10.1007/s00277-008-0590-9 · Cited by 18
“2004, some non-HFE-related forms of haemochromatosis were identified, and these rare conditions were successively related to mutations in the genes that encode transferrin receptor 2 (TFR2) [9], ferroportin 1 (SLC40A1) [25], hepcidin (HAMP) [ 26 ] and haemojuvelin (HJV) [15, 23].”
BackgroundWallace, D. F., & Subramaniam, V. N. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-485-2_20 · Cited by 18
Altés, A., Bach, V., Ruiz, A., Esteve, A., Félez, J., Remacha, A. F., Sardà, M. P., & Baiget, M. (2009) · Annals of Hematology · doi:10.1007/s00277-009-0705-y · Cited by 19
“Other forms of hemochromatosis include type 2 or juvenile hemochromatosis, which can be caused by mutations in the HAMP, the gene coding for the iron regulatory peptide hepcidin [ 21 ] or in the hemojuvelin gene [18].”
BackgroundHepcidin generated by hepatoma cells inhibits iron export from co-cultured THP1 monocytes
Andriopoulos, B., & Pantopoulos, K. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.10.025 · Cited by 19
“Genetic mutations leading to complete silencing of hepcidin are etiologically linked to a rare form of juvenile hemochromatosis [10], an early onset disease of iron overload characterized by pathological iron absorption and deposition within parenchymal cells with a relative sparing of macrophages [11].”
BackgroundScreening for hemochromatosis: Patients with liver disease, families, and populations
Galhenage, S., Viiala, C. H., & Olynyk, J. K. (2004) · Current Gastroenterology Reports · doi:10.1007/s11894-004-0025-2 · Cited by 19
New Mutations in HFE2 and TFR2 Genes Causing Non HFE-Related Hereditary Hemochromatosis
Hernández, G., Ferrer-Cortés, X., Venturi, V., Musri, M. M., Pilquil, M. F., Muñoz-Torres, P., Hernández‐Rodríguez, I., Mínguez, M. Á. R., Kelleher, N. J., Pelucchi, S., et al. (2021) · Genes · doi:10.3390/genes12121980 · Cited by 18
The role of heparin, heparanase and heparan sulfates in hepcidin regulation
Asperti, M., Denardo, A., Gryzik, M., Arosio, P., & Poli, M. (2019) · Vitamins and hormones · doi:10.1016/bs.vh.2019.01.008 · Cited by 18
Iron absorption in hepcidin1 knockout mice
Masaratana, P., Laftah, A. H., Latunde-Dada, G. O., Vaulont, S., Simpson, R. J., & McKie, A. T. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114510005507 · Cited by 17
Iron as a Therapeutic Target in HFE-Related Hemochromatosis: Usual and Novel Aspects
Loréal, O., Cavey, T., Robin, F., Kenawi, M., Guggenbuhl, P., & Brissot, P. (2018) · Pharmaceuticals · doi:10.3390/ph11040131 · Cited by 18
“Homozygous and compound heterozygous mutations in the HAMP [63] or HJV [64] genes induce an early and severe iron overload disease (juvenile hemochromatosis) that is related to severe hepcidin deficiency with major complications that quickly impact well-being and life expectancy.”
BackgroundHemojuvelin: a supposed role in iron metabolism one year after its discovery
Celec, P. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0668-y · Cited by 18
“The symptoms of juvenile hemochromatosis caused by hepcidin mutations seem to be more severe than those caused byHJVmutations [29].”
BackgroundFerrara, F., Corradini, E., & Pietrangelo, A. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-963-9_54 · Cited by 17
Inherited metabolic liver disease
Schilsky, M. L., & Fink, S. A. (2006) · Current Opinion in Gastroenterology · doi:10.1097/01.mog.0000218957.63311.0e · Cited by 18
Gobbi, M. D., Daraio, F., Oberkanins, C., Moritz, A., Kury, F., Fiorelli, G., & Camaschella, C. (2003) · PubMed · Cited by 19
Self-citationFerroptosis in heart failure: from molecular insights to therapeutic implications
Karampinos, K. I., Farmakis, D. T., Gurung, R., Foo, R., Filippatos, G. S., & Cokkinos, D. V. (2026) · Cardiovascular Research · doi:10.1093/cvr/cvag019 · Cited by 18
Smith, K. J., & Findlay, E. G. (2022) · Discovery Immunology · doi:10.1093/discim/kyac003 · Cited by 16
“Mutations in HAMP have been identified in patients suffering from hereditary hemochromatosis [121].”
BackgroundTMPRSS6 gene polymorphisms associated with iron deficiency anaemia among global population
Atan, F. N. E. M., Saman, W. A. W. M., Kamsani, Y. S., Khalid, Z., & Rahman, A. A. (2022) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-022-00362-1 · Cited by 18
Wang, S., Chen, C., Yu, L., Mueller, J. H., Rausch, V., & Mueller, S. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101378 · Cited by 17
“Consequently, its overexpression leads to hypoferremia and anemia (8), whereas suppression of hepcidin causes iron overload (9).”
BackgroundIron in blood cells: Function, relation to disease, and potential for magnetic separation
Barua, S., Ciannella, S., Tijani, L., & Gómez‐Pastora, J. (2023) · Biotechnology and Bioengineering · doi:10.1002/bit.28388 · Cited by 20
Is Hepcidin a New Cardiovascular Risk Marker in Polycystic Ovary Syndrome?
Gözdemir, E., Kaygusuz, İ., & Kafalı, H. C. (2013) · Gynecologic and Obstetric Investigation · doi:10.1159/000348497 · Cited by 16
The regulation of iron metabolism in the mononuclear phagocyte system
Kong, W.-N., Lei, Y., & Chang, Y. (2013) · Expert Review of Hematology · doi:10.1586/17474086.2013.814840 · Cited by 17
Iron-deficiency anemia secondary to mutations in genes controlling hepcidin
Cau, M., Melis, M. A., Congiu, R., & Galanello, R. (2010) · Expert Review of Hematology · doi:10.1586/ehm.10.2 · Cited by 19
Recent advances in cellular iron metabolism
Ponka, P. (2003) · The Journal of Trace Elements in Experimental Medicine · doi:10.1002/jtra.10035 · Cited by 20
Gobbi, M. D., D’Antico, S., Castagno, F., Testa, D., Merlini, R., Bondi, A., & Camaschella, C. (2004) · PubMed · Cited by 18
Self-citationFranchini, M., & Veneri, D. (2005) · Hematology · doi:10.1080/10245330500065771 · Cited by 19
Impact of hepcidin antimicrobial peptide on iron overload in tuberculosis patients
Javaheri-Kermani, M., Farazmandfar, T., Ajami, A., & Yazdani, Y. (2014) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2014.929736 · Cited by 15
An, P., Jiang, L., Guan, Y., Wang, H., Wang, J., Tian, Y., Yang, W., Shi, Y., Xue, J., Min, J., et al. (2017) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2017.01.002 · Cited by 16
Iron Status Biomarkers and Cardiovascular Risk
Vaquero, M. P., García-Quismondo, Á., Cañizo, F. J., & Sánchez-Muniz, F. J. (2017) · InTech eBooks · doi:10.5772/intechopen.69040 · Cited by 15
“Sequencing of HAMP reveals several mutations that are either not functional [17] or related to a rare form of hemochromatosis [18] indicating low variability and that this gene is highly conserved in humans while the common iron metabolism alterations, either iron deficiency or hemochromatosis, have been associated wi…”
BackgroundDirect modulation of hepatocyte hepcidin signaling by iron
Yu, L., Wang, S., Chen, C., Rausch, V., Elshaarawy, O., & Mueller, S. (2021) · World Journal of Hepatology · doi:10.4254/wjh.v13.i10.1378 · Cited by 17
Bagu, E. T., Layoun, A., Calvé, A., & Santos, M. M. (2013) · BioMetals · doi:10.1007/s10534-013-9683-6 · Cited by 17
Bagu, E. T., & Santos, M. M. (2011) · Journal of Molecular Endocrinology · doi:10.1530/jme-11-0060 · Cited by 15
Militaru, M. S., Popp, R. A., & Trifa, A. P. (2010) · PubMed · Cited by 15
Haemochromatosis: Pathophysiology and the red blood cell1
Richardson, K. J., McNamee, A. P., & Simmonds, M. J. (2018) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-189128 · Cited by 16
“While most juvenile haemochromatosis cases are caused by mutations to the HJV gene, a small number of cases (referred to as type 2B haemochromatosis) are induced by a mutation in the HAMP gene (crucial for hepcidin expression), with substitution of cysteine for arginine at codon 70 or cysteine for tyrosine at codon 78…”
Mao, P., Wortham, A. M., Enns, C. A., & Zhang, A. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006468 · Cited by 15
“Lack of hepcidin causes juvenile hemochromatosis, a severe form of iron overload (11, 12).”
BackgroundIschemia‐reperfusion of rat liver modulates hepcidin in vivo expression
Goss, J. A., Seu, P., Gao, F. Q., & Wyllie, S. (2005) · Liver Transplantation · doi:10.1002/lt.20436 · Cited by 16
Hematologically important mutations: iron storage diseases
Beutler, L. R., & Beutler, E. (2004) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2004.03.002 · Cited by 15
Intestinal absorption of iron in HFE-1 hemochromatosis: local or systemic process?
Brissot, P., Troadec, M., & Loréal, O. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.01.020 · Cited by 19
A genome‐wide linkage scan for iron phenotype quantitative trait loci: the HEIRS Family Study
Acton, R. T., Snively, B., Barton, J. C., McLaren, C., Adams, P. C., Rich, S. S., Eckfeldt, J. H., Press, R. D., Sholinsky, P. D., Leiendecker-Foster, C., et al. (2007) · Clinical Genetics · doi:10.1111/j.1399-0004.2007.00804.x · Cited by 15
Primary Non-HFE Hemochromatosis: A Review
Turshudzhyan, A., Wu, D. C., & Wu, G. Y. (2023) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00373 · Cited by 17
Clinical and Molecular Aspects of Iron Metabolism in Failing Myocytes
Kozłowska, B., Sochanowicz, B., Kraj, L., Palusińska, M., Kołsut, P., Szymański, Ł., Lewicki, S., Kruszewski, M. K., Załęska‐Kocięcka, M., & Leszek, P. (2022) · Life · doi:10.3390/life12081203 · Cited by 14
“The most crucial iron regulator in the body is hepcidin (HEPC)—an iron-regulatory hormone encoded by HAMP (hepcidin anti-microbial peptide; type 2B) and mainly produced by the liver [56].”
BackgroundCavey, T., Latour, C., Island, M., Leroyer, P., Guggenbuhl, P., Coppin, H., Roth, M., Bendavid, C., Brissot, P., Ropert, M., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201801381rr · Cited by 14
“FASEB Journal, Federation of American Society of Experimental Biology, 2019, 33 (10), pp.”
BackgroundHémochromatose HFE : approche pathogénique et diagnostique
Brissot, P., Lan, C. L., Troadec, M., Lorho, R., Ropert, M., Lescoat, G., & Loréal, O. (2005) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2005.04.040 · Cited by 14
Milman, N. T., Koefoed, P., Pedersen, P. L., Nielsen, F. C., & Eiberg, H. (2003) · European Journal Of Haematology · doi:10.1046/j.0902-4441.2003.00156.x · Cited by 14
“described causing autosomal recessive haemochromatosis (50).”
Hepcidin and the anemia of chronic disease.
Haurani, F. I. (2006) · PubMed · Cited by 18
Hepcidin Is a Valuable Therapeutic Target for Colorectal Cancer
Frascatani, R., Colella, M., & Monteleone, G. (2024) · Cancers · doi:10.3390/cancers16234068 · Cited by 13
“This is seen, for example, in both humans and mice with genetic hepcidin loss, which causes severe forms of iron overload [11,12].”
Viprakasit, V., Vathesathokit, P., Chinchang, W., Tachavanich, K., Pung‐Amritt, P., Wimhurst, V. L. C., Yenchitsomanus, P., Merryweather‐Clarke, A. T., & Tanphaichitr, V. S. (2004) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2004.00246.x · Cited by 16
Herruzo, J. A. S., & Muñoz, P. S. (2005) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082005000400007 · Cited by 15
Iron metabolism in the mononuclear phagocyte system
Kong, W., Duan, X., Shi, Z., & Chang, Y. (2008) · Progress in Natural Science Materials International · doi:10.1016/j.pnsc.2008.03.024 · Cited by 15
“Mutations in hepcidin can increase intestinal iron absorption and macrophages iron release, and eventually lead to overaccumulation of iron in the liver [46].”
BackgroundLes hémochromatoses. Nouvelle compréhension, nouveaux traitements
Brissot, P. (2009) · Gastroentérologie Clinique et Biologique · doi:10.1016/j.gcb.2009.04.004 · Cited by 13
“[8] Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, Christakis J, et al.”
Comparative analysis of Xenopus tropicalis hepcidin I and hepcidin II genes
Hu, X., Ward, C. K., Aono, S., 兰利琼, Dykstra, C. C., Kemppainen, R. J., Morrison, E. E., & Shi, J. N. (2008) · Gene · doi:10.1016/j.gene.2008.08.022 · Cited by 13
Lee, P. L., Promrat, K., Mallette, C., Flynn, M., & Beutler, E. (2006) · Acta Haematologica · doi:10.1159/000089479 · Cited by 13
“Less commonly, juvenile hemochromatosis is the result of a mutation in HAMP, the gene that encodes hepcidin [”
BackgroundErythroferrone and hepcidin levels in children with iron deficiency anemia
Dulkadir, R., Saltoğlu, G. T., & Gunes, A. E. (2024) · BMC Pediatrics · doi:10.1186/s12887-024-04594-5 · Cited by 12
Maxwell, K., Chuang, J., Chaudhry, M. A., Nie, Y., Bai, F., Sodhi, K., Liu, J., & Shapiro, J. I. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00244.2020 · Cited by 12
Hereditary Hemochromatosis (HFE) genotypes in heart failure: Relation to etiology and prognosis
EchoCardiography and Heart Outcome Study (ECHOS) investigators, Møller, D. V., Pecini, R., Gustafsson, F., Hassager, C., Hedley, P. L., Jespersgaard, C., Torp-Pedersen, C. T., Christiansen, M., & Køber, L. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-117 · Cited by 12
“Mutations within several genes have been associated with HH, these include hemochromatosis (HFE), hemojuvelin (HJV)[3], transferrin receptor 2 (TfR2)[4], and hepcidin (HAMP)[5].”
BackgroundNon-HFE hemochromatosis: Genetics, pathogenesis, and clinical management
Nelson, J. E., & Kowdley, K. V. (2005) · Current Gastroenterology Reports · doi:10.1007/s11894-005-0069-y · Cited by 12
“Three of these, the C78T [34], 93delG [ 35 ], and a G-to-A transition at nucleotide +14 (which creates an alternative initiation codon) [36], are private mutations ( ie , mutations unique to a particular family).”
BackgroundSebastiani, G., & Pantopoulos, K. (2010) · CRC Press eBooks · doi:10.1201/9781420059984-c13 · Cited by 12
Ramzan, K., Imtiaz, F., Al-Ashgar, H. I., Alsayed, M. D., & Sulaiman, R. A. (2017) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2017.03.011 · Cited by 12
Splicing variant of hepcidin mRNA
Sasaki, K., Kohgo, Y., & Ohtake, T. (2019) · Vitamins and hormones · doi:10.1016/bs.vh.2019.01.006 · Cited by 12
Molecular basis of hereditary iron homeostasis defects
Horváthová, M., Ponka, P., & Divoký, V. (2010) · Hematology · doi:10.1179/102453310x12583347009810 · Cited by 13
Runx3 regulates iron metabolism via modulation of BMP signalling
Kim, H., Lee, J., Lee, Y., Li, S., Lee, S., Bae, S., & Jung, H.-S. (2021) · Cell Proliferation · doi:10.1111/cpr.13138 · Cited by 11
A Late Presentation of a Fatal Disease: Juvenile Hemochromatosis
Cherfane, C. E., Lee, P. L., Guerin, L., & Brown, K. E. (2013) · Case Reports in Medicine · doi:10.1155/2013/875093 · Cited by 11
“A similar phenotype results frommutations in the gene encoding hepcidin itself, which accounts for the remaining 10% of cases of JH (type 2B) [19].”
BackgroundLee, P. L., Rice, L., McCarthy, J. J., & Beutler, E. (2008) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2008.08.001 · Cited by 12
“Specifically, no mutations were identified in HFE, β2 microglobulin, transferrin receptor-2 (TfR2), ferroportin (SLC40A1), hemojuvelin (HJV) and hepcidin (HAMP) genes.”
BackgroundInfluentialSrai, S. K., & Sharp, P. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-485-2_1 · Cited by 15
Brakensiek, K., Fegbeutel, C., Mälzer, M., Strüber, M., Kreipe, H. H., & Stuhrmann, M. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01261.x · Cited by 11
“JH is subdivided into two forms, designated as HFE2A and HFE2B, which are caused by mutations in the genes encoding hemojuvelin (HJV ; MIM 608374) and hepcidin antimicrobial peptide (HAMP ; MIM 606464), respectively (2, 3).”
BackgroundHereditary hemochromatosis: An opportunity for gene therapy
Ezquer, F. E., Núñez, M. T., Rojas‐Fernández, A., Asenjo, J. A., & Israel, Y. (2006) · Biological Research · doi:10.4067/s0716-97602006000100014 · Cited by 15
“Complete hepcidin deficiency resulting in juvenile hemochromatosis appears to be uncommon (Roetto et al., 2003).”
Hemojuvelin and Hepcidin Genes Sequencing in Brazilian Patients with Primary Iron Overload
Santos, P. C. J. L., Pereira, A. C., Cançado, R. D., Schettert, I. T., Hirata, R. D. C., Hirata, M. H., Figueiredo, M. S., CHIATTONE, C. S., Krieger, J. E., & Guerra‐Shinohara, E. M. (2010) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2010.0056 · Cited by 11
Knisely, A. S., & Narkewicz, M. R. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511547409.029 · Cited by 11
Identification, sequencing, and cellular localization of hepcidin in guinea pig (Cavia porcellus)
Schwarz, P., Strnad, P., Singer, N., Oswald, F., Ehehalt, R., Adler, G., & Kulaksiz, H. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0191 · Cited by 12
“2001) similar to iron overload patterns in patients suffering from hereditary hemochromatosis (Roetto et al. 2003).”
BackgroundLuo, X. L., Jiang, Q., Song, G., Liu, Y., Xu, Z., & Guo, Z. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08695.x · Cited by 10
Pointon, J. J., Lok, C. Y., Shearman, J. R., Suckling, R. J., Rochette, J., Merryweather‐Clarke, A. T., & Robson, K. (2009) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2009.04.007 · Cited by 11
Molecular diagnosis of genetic iron-overload disorders
Brissot, P., Bardou‐Jacquet, E., Troadec, M., Mosser, A., Island, M., Détivaud, L., Loréal, O., & Jouanolle, A. (2010) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.55 · Cited by 10
Frýdlová, J., Rychtarčíková, Z., Gurieva, I., Vokurka, M., Truksa, J., & Krijt, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186844 · Cited by 10
“Hepcidin, encoded by the HAMP gene, controls iron metabolism by blocking the passage of iron from the diet to the bloodstream at the level of iron export from the enterocyte; decreased production of hepcidin results in increased uptake of iron from the diet and iron overload [10].”
Genetic background of Japanese patients with adult‐onset storage diseases in the liver
Hayashi, H., Wakusawa, S., Yano, M., & Okada, T. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00114.x · Cited by 10
Le mécanisme d’action de l’hepcidine déchiffré
Nicolas, G., & Vaulont, S. (2005) · médecine/sciences · doi:10.1051/medsci/20052117 · Cited by 12
An Update on Iron Homeostasis: Make New Friends, but Keep the Old
Roy, C. N. (2013) · The American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000190 · Cited by 11
Metadata
- Authors
- Roetto, A., Papanikolaou, G., Politou, M., Alberti, F., Girelli, D., Christakis, J., Loukopoulos, D., & Camaschella, C.
- Affiliations
- Ospedale San Luigi Gonzaga (IT)
- National and Kapodistrian University of Athens (GR)
- University of Verona (IT)
- Theageneio General Hospital (GR)
- Corresponding author
- Camaschella, Clara
- ORCID
- Venue
- Nature Genetics
- Published
- 2002-12-09
- Volume
- 33
- Issue
- 1
- Pages
- 21-22
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2056282179
- Cited by
- 860
- References
- 16
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 9 · 2023: 13 · 2022: 14 · 2021: 25 · 2020: 23 · 2019: 14 · 2018: 19 · 2017: 35 · 2016: 23 · 2015: 32 · 2014: 28 · 2013: 37 · 2012: 37
- FWCI
- 32.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- hepcidin, juvenile hemochromatosis, antimicrobial peptides, iron absorption regulation, 19q13, hereditary hemochromatosis
- MeSH terms
- Amino Acid Sequence, Base Sequence, Child, DNA Mutational Analysis, Female, Hemochromatosis, Humans, Male, Molecular Sequence Data, Mutation, Pedigree, Polymorphism, Single-Stranded Conformational, Antimicrobial Cationic Peptides, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.